Literature DB >> 12119569

Influence of obesity on cardiovascular risk. Twenty-three-year follow-up of 22,025 men from an urban Swedish population.

S Jonsson1, B Hedblad, G Engström, P Nilsson, G Berglund, L Janzon.   

Abstract

OBJECTIVE: To assess to what extent the incidence of coronary events and death related to smoking, hypertension, hyperlipidemia and diabetes is modified by obesity.
DESIGN: Prospective cohort study.
SUBJECTS: A total of 22 025 men aged 27 to 61-y-old at entry. MEASUREMENTS: Incidence of coronary events (CE, ie acute myocardial infarctions and deaths due to chronic ischaemic heart disease) and death during 23 y of follow-up was studied in relation to body mass index (BMI), heart rate, blood pressure, blood lipids, glucose and insulin, lifestyle factors, history of angina pectoris, history of cancer, self-reported health and socio-economic conditions.
RESULTS: At the end of follow-up 20% of the obese men were no longer alive, and 13% had had a coronary event. Incidence of CE was 16% lower (RR (relative risk) 0.84; 95% confidence interval (CI) 0.65-1.10) among underweight (n=1171), 24% higher (RR 1.24; CI 1.12-1.37) among overweight (n=7773), and 76% higher (RR 1.76; 95% CI 1.49-2.08) among obese men (n=1343) than it was among men with normal BMI (n=11 738). The risk associated with overweight and obesity remained statistically significant after adjustment for potential confounders (RR 1.18; CI 1.07-1.31; and 1.39; 1.17-1.65, respectively). The association between BMI and mortality was J-shaped. In all, 1.7% of the obese men were smokers with hypertension, hyperlipidaemia and diabetes, 16.3% were not exposed to any of these risk factors. The cardiovascular risk associated with obesity was small in the absence of other risk factors. Between smoking and obesity there was a statistically significant synergistic effect.
CONCLUSIONS: Obesity is associated with an increased incidence of coronary events and death. The risk associated with obesity is substantially increased by exposure to other atherosclerotic risk factors, of which smoking seems to be the most important. The preventive potential of these associations should be evaluated in controlled trials.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12119569     DOI: 10.1038/sj.ijo.0802060

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  39 in total

Review 1.  Age-related cardiovascular disease and the beneficial effects of calorie restriction.

Authors:  Miranda M Y Sung; Jason R B Dyck
Journal:  Heart Fail Rev       Date:  2012-09       Impact factor: 4.214

2.  Obesity and the risk of disability in a 12-year cohort study: the role of psychological distress.

Authors:  Genevieve Gariepy; Jianli Wang; Alain Lesage; Norbert Schmitz
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2010-09-17       Impact factor: 4.328

Review 3.  Cardiovascular risk in the metabolic syndrome: fact or fiction?

Authors:  Peter M Nilsson
Journal:  Curr Cardiol Rep       Date:  2007-11       Impact factor: 2.931

4.  The bigger the healthier: are the limits of BMI risk changing over time?

Authors:  R Max Henderson
Journal:  Econ Hum Biol       Date:  2005-10-03       Impact factor: 2.184

5.  The influence of laparoscopic sleeve gastrectomy on metabolic syndrome parameters in obese patients in own material.

Authors:  Hady Razak Hady; Jacek Dadan; Magdalena Luba
Journal:  Obes Surg       Date:  2012-01       Impact factor: 4.129

6.  Overweight and obesity and weight change in middle aged men: impact on cardiovascular disease and diabetes.

Authors:  S Goya Wannamethee; A Gerald Shaper; Mary Walker
Journal:  J Epidemiol Community Health       Date:  2005-02       Impact factor: 3.710

7.  Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients.

Authors:  K Eeg-Olofsson; J Cederholm; P M Nilsson; B Zethelius; L Nunez; S Gudbjörnsdóttir; B Eliasson
Journal:  Diabetologia       Date:  2008-11-05       Impact factor: 10.122

8.  Attitudes and reported practice for obesity management in Korea after introduction of anti-obesity agents.

Authors:  Hye Soon Park; Jee-Young Park; Hong-Jun Cho
Journal:  J Korean Med Sci       Date:  2005-02       Impact factor: 2.153

9.  Weight loss, glycemic control, and changes in cardiovascular biomarkers in patients with type 2 diabetes receiving incretin therapies or insulin in a large cohort database.

Authors:  Edward S Horton; Cheryl Silberman; Keith L Davis; Rachele Berria
Journal:  Diabetes Care       Date:  2010-05-11       Impact factor: 19.112

10.  Visceral adiposity and subclinical coronary artery disease in elderly adults: Rancho Bernardo Study.

Authors:  Dong-Jun Kim; Jaclyn Bergstrom; Elizabeth Barrett-Connor; Gail A Laughlin
Journal:  Obesity (Silver Spring)       Date:  2008-02-28       Impact factor: 5.002

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.